drugset / Trial / NCT04731818

An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film

NCT04731818 ↗

Phase 0 Completed 20 enrolled KBio Inc Eastern Virginia Medical School · collab
NaSingle-groupOpen-labelPrevention

Summary

This is an early Phase 1 study to establish proof-of-concept by determining whether an intravaginal film containing a human contraceptive antibody (ZB-06) shows promise to provide contraceptive efficacy using the post-coital test, a surrogate measure of efficacy. The study will also evaluate the safety and pharmacokinetics of ZB-06.

Timeline

Start
2021-02-08
Primary completion
2022-01-25
Completion
2022-02-24

Outcome

Met primary endpoint

paper After use of a single ZB-06 film before intercourse, this number dropped to 0.04 (±0.06) progressively motile sperm per high-power field (P<.0001). PMID 36870409 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject HC4-N Unknown 20 mg Topical

Indications

No indication recorded.